HARROW HEALTH, INC. (IMMY) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues:
Total revenues	33.5	26.1	20.3	22.8	23.3	22.1	20.2	18.7
Total revenues growth	43.5%	18.0%	0.7%	22.0%	28.6%	43.2%	38.3%	29.9%
Cost of sales	-10.0	-8.3	-6.2	-6.7	-6.5	-6.0	-5.1	-4.9
Gross profit	23.5	17.8	14.2	16.1	16.8	16.2	15.1	13.8
Gross margin	70.1%	68.3%	69.7%	70.6%	72.0%	73.0%	74.8%	73.6%

Operating expenses:
Selling, general and administrative	20.0	15.9	15.2	15.4	14.2	13.4	12.7	11.4
Research and development	1.2	0.7	0.7	0.8	0.9	0.7	3.9	6.1
Total operating expenses	21.1	16.6	79.2	16.2	15.1	14.1	71.1	17.5
Income from operations	2.4	1.2	-1.8	-0.1	1.7	2.1	-1.8	-3.7
Operating margin	7.0%	4.6%	-8.7%	-0.4%	7.2%	9.5%	-8.7%	-19.9%

Other(expense) income :
Interest expense, net	-5.7	-4.7	-1.9	-1.8	-1.8	-1.8	-1.9	-1.7
Equity in losses of unconsolidated entities			-2.1	-3.5	-2.6	-2.9	-2.4	-0.7
Investment (loss) gain from Eton Pharmaceuticals	-0.7	2.0	1.4	-1.0	-3.4	0.1	-1.5	-2.2

Loss on extinguishment of debt
Other expense, net	-0.2	0.0					0.2
Total other expense, net	-6.6	-8.1	2.8	-6.3	-7.9	-4.5	-5.5	-4.6
Loss before income taxes	-4.2	-6.9	1.1	-6.4	-6.2	-2.4	-7.3	-8.3
Income tax benefit (expense)	0.0	0.3		0.0	0.0
Net loss attributable to Harrow Health, Inc.	-4.2	-6.6	1.1	-6.5	-6.2	-2.4	-7.4	-8.3

Basic net loss per share of common stock	($0.14)	($0.22)	$0.04	($0.24)	($0.23)	($0.09)	($0.27)	($0.31)
Diluted net loss per share of common stock	($0.14)	($0.22)	$0.04	($0.24)	($0.23)	($0.09)	($0.27)	($0.31)

Weighted average number of shares of common stock outstanding, basic	30.5	30.3	27.5	27.3	27.3	27.2	26.8	27.1
Weighted average number of shares of common stock outstanding, diluted	30.5	30.3	27.5	27.3	27.3	27.2	26.8	27.1